Latest Asx Listing Rules News

Sky Metals Ltd has confirmed its recent trading halt was requested pending a material capital raising announcement, affirming compliance with ASX disclosure rules.

Weebit Nano has responded to an ASX price query following a sharp rise in its share price and trading volume, attributing the activity to a misleading article on the Motley Fool website. The company denies any undisclosed price-sensitive information and confirms full compliance with ASX disclosure rules.

Orbminco Limited is proposing a 20 – 1 consolidation of its issued shares to streamline its capital structure and broaden investor appeal, with shareholder approval sought in September.

Ausmon Resources has addressed a recent spike in its share price and trading volume, attributing the market interest to prior drilling assay results for rare earth elements in South Australia.

iTech Minerals has confirmed it will soon announce new high-grade antimony findings at its Reynold Range Project, following a notable uptick in its share price and trading volume.

Andromeda Metals has addressed recent share price gains and trading volume spikes, attributing the activity to ongoing funding efforts and strategic project studies rather than undisclosed information.

Kaili Resources addresses ASX price query following a dramatic surge in its share price and trading volume, attributing the movement to its recent rare earth element drilling approval in South Australia.

Platinum Asia Investments Limited (PAI) shares have been suspended following Federal Court approval of a scheme exchanging all shares for units in the Platinum Asia Fund Complex ETF (PAXX). This marks a significant structural shift for PAI investors.

Kaili Resources has addressed a sharp spike in its share price and trading volume, attributing the market interest to its recent approval for rare earth element drilling in South Australia, while confirming no undisclosed material information.

Australian Strategic Materials has announced the vesting of over 400,000 performance rights granted to its Managing Director and senior executives, marking a key moment in executive remuneration and potential share dilution.

Australian Bond Exchange Holdings has responded to ASX queries confirming the material impact of its involvement in the RBA's Project Acacia and acknowledged a director's breach of trading rules during a closed period.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.